In silico Identification of HDAC Inhibitors for Multiple Myeloma: A Structure-based Virtual Screening, Drug Likeness, ADMET Profiling, Molecular Docking, and … A Debnath, R Mazumder, A Mazumder, R Singh, S Srivastava Letters in Drug Design & Discovery 21 (5), 961-978, 2024 | 12 | 2024 |
A brief study on drug repurposing: new way of boosting drug discovery KK Kaushik, R Mazumder, A Debnath, M Patel Letters in Drug Design & Discovery 20 (3), 264-278, 2023 | 7 | 2023 |
Advancements of glucose monitoring biosensor: current state, generations of technological progress, and innovation dynamics A Dua, A Debnath, K Kumar, R Mazumder, A Mazumder, R Singh, ... Current Pharmaceutical Biotechnology, 2025 | 4 | 2025 |
Identification of novel CDK 4/6 inhibitors by high-throughput virtual screening A Debnath, R Mazumder Letters in Drug Design & Discovery 21 (15), 3229-3246, 2024 | 4 | 2024 |
A brief description of COVID-19 pulmonary viral infection and repurposing of drugs for its treatment M Patel, R Mazumder, KK Kaushik, A Debnath, R Mishra, S Pal PATEL M, MAZUMDER R, KAUSHIK KK, DEBNATH A, MISHRA R, PAL S. A BRIEF …, 2022 | 4 | 2022 |
Experimental, quantum chemical spectroscopic investigation, topological, molecular docking/dynamics and biological assessment studies of 2, 6-Dihydroxy-4-methyl quinoline RC Joshi, S Husain, N Pandey, N Fatma, D Bisen, R Upadhyay, ... Journal of Molecular Structure 1321, 140123, 2025 | 3 | 2025 |
Discovery of novel CDK4/6 inhibitors from fungal secondary metabolites A Debnath, R Mazumder, RK Singh, AK Singh International Journal of Biological Macromolecules 282, 136807, 2024 | 3 | 2024 |
Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance N Sharma, R Mazumder, P Rai, A Debnath Chemical Biology & Drug Design 104 (3), e14613, 2024 | 3 | 2024 |
Clinical progress of targeted therapy for breast cancer: A comprehensive review A Debnath, R Mazumder Curr Cancer Drug Targets 24, 9091, 2024 | 3 | 2024 |
A Deep Dive into PDE5 Inhibition: Innovative Discoveries via Virtual Screening A Debnath, H Chaudhary, P Sharma, R Singh, S Srivastava Letters in Drug Design & Discovery 21 (16), 3425-3442, 2024 | 2 | 2024 |
miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement A Debnath, R Mazumder, A Mazumder, S Tripathi, A Dua, R Singh, ... Current gene therapy, 2024 | 2 | 2024 |
Kidney targeting approaches In The Drug Delivery arena Singh S, Mazumder R, Debnath A, Dutta A NeuroQuantology 20 (8), 3424-3444, 2022 | 2 | 2022 |
PD 1: A Trending Target in Anti-cancer Research S Rani, R Mazumder, N Sharma, R Mishra, A Debnath, SD Paul Biointerface Research in Applied Chemistry 13 (3), 218, 2022 | 2 | 2022 |
Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes S Mangal, A Debnath, R Mazumder, A Mazumder, RK Singh, J Sanchitra, ... All Life 17 (1), 2417192, 2024 | 1 | 2024 |
Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening A Debnath, A Rani, R Mazumder, A Mazumder, RK Singh, S Sharma, ... Current Computer-Aided Drug Design, 2024 | 1 | 2024 |
In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening A Debnath, S Sharma, R Mazumder, A Mazumder, R Singh, A Kumar, ... Current Drug Discovery Technologies 21 (3), 20-31, 2024 | 1 | 2024 |
Discovery of Novel Cathepsin D Inhibitors by High-Throughput Virtual Screening A Debnath, H Chaudhary, R Kumar, A Shokeen, R Khurana neurodegenerative diseases 9, 10, 2023 | 1 | 2023 |
Integration of In-vivo screening, molecular docking, and molecular dynamics simulations for studying the antiepileptic potential of newly synthesized 5-naphthalen-1-yl-5, 10 … R Kumar, H Singh, A Debnath, A Mazumder, N Bano, V Khanna, ... Journal of Molecular Structure 1324, 140814, 2025 | | 2025 |
Targeting Undruggable Proteins: The siRNA Revolution Beyond Small Molecules-Advances, Challenges, and Future Prospects in Therapeutic Innovation SKA Jan, A Debnath, RK Singh, PK Tyagi, S Singh, AK Singh Current Gene Therapy, 2025 | | 2025 |
Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products A Debnath, R Mazumder, AK Singh, RK Singh Plos one 20 (1), e0313830, 2025 | | 2025 |